CTRI/2024/05/066914
Not yet recruiting
Phase 2
Comparative efficacy of combined pharmacotherapy (Ibuprofen + Paracetamol) versus monotherapy (Ibuprofen) in the treatment of hemodynamically significant PDA - A Double Blind Randomised Controlled Trial at a level III NICU in LMIC - NI
Govind Choudhary0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: Q250- Patent ductus arteriosus
- Sponsor
- Govind Choudhary
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Preterm neonates less than 32 week admitted in the NICU with hemodynamically significant PDA between 12 and 72 hours of life.
- •2\. Written Informed parental or guardian consent obtained
Exclusion Criteria
- •1\. Major lethal congenital malformations
- •2\.Echocardiographic evidence of pulmonary hypertension.
- •3\. IVH grade III or more
- •4\. Platelet count less than 50,000/mm3
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Investigating the effect of platelet-rich plasma in androgenetic alopeciaAndrogenetic alopecia.Androgenic alopeciaIRCT20221230056991N1Esfahan University of Medical Sciences60
Not yet recruiting
Phase 3
Comparison of the effectiveness of combined treatment of topical L-carnitine lotion 1% with clotrimazole lotion 2% and clotrimazole lotion 2% alone in the treatment of seborrheic dermatitis of the head (scalp)IRCT20150706023081N4Esfahan University of Medical Sciences64
Completed
Not Applicable
Comparison of the therapeutic benefit to combination therapy of botulinum neurotoxin and cast as well as single dose of botulinum neurotoxin on the wrist spasticity in different time intervalsG81.1I63.9Spastic hemiplegiaCerebral infarction, unspecifiedDRKS00010413eurologisches Rehabilitationszentrum Leipzig60
Not yet recruiting
Phase 4
comparison of newer and higher dose antibiotics combination therapy with old and standard antibiotics combination therapy in critically ill patients who are carbapenem resistant enterobacteriaceae (CRE)Health Condition 1: R799- Abnormal finding of blood chemistry, unspecifiedCTRI/2022/09/045736Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh
Completed
Not Applicable
Combination therapy in rheumatoid arthritisISRCTN18445519Turku University Hospital (Finland)199